From the magazine LSR 1/2019 | S. 15-33 The following page is 15

Financial Transparency in Industry-Physician Relationships

Part I: Analysis and Critical Assessment of the Swiss Pharma Cooperation Code

I. Goals of the Pharma Cooperation Code in View of the Literature

A long stream of empirical studies has confirmed that conflicts of interests1 are common in the health sector.2 Conflicts of interests are not inherently “evil”, but they do have the potential to bias doctors’ judgments – what has also been established by further empirical studies.3

Aus der ZeitschriftLSR 1/2019 | S. 15–33 Es folgt Seite № 16Indeed, if a doctor feels indebted to a pharmaceutical company which has offered her gifts, has invited her to seminars, had included her on advisory boards or has paid for her research, she may feel more inclined to choose and prescribe that company’s medical products – even if they are more expensive or less adequate for the patient. If this happens, it will be most often unconscious on the part of the doctor.4 Of course, the reverse may also occur: some doctors may refuse all offers coming from pharmaceutical companies;5 others may accept them,…

[…]
Melden sie sich für den LSR Newsletter an und bleiben Sie informiert.